Business Plan for the establishment of an Anti-rabies Center in Thessaloniki by Tasioudi, Konstantia E.
  
 
 
Business Plan  
for the Establishment 
of an Anti-rabies Center  
in Thessaloniki 
 
Konstantia E. Tasioudi 
SCHOOL OF ECONOMICS, BUSINESS ADMINISTRATION & LEGAL STUDIES 
A thesis submitted for the degree of 
Executive MBA 
 
January 2019 
Thessaloniki – Greece 
  
 
I hereby declare that the work submitted is mine and that where I have made use of another’s 
work, I have attributed the source(s) according to the Regulations set in the Student’s Handbook. 
 
 
 
 
 
 
 
 
January 2019 
Thessaloniki – Greece 
 
 
 
 
 
 
 
Student Name: Konstantia E. Tasioudi 
SID: 1101170009 
Supervisor: Prof. Korina Katsaliaki 
Front cover picture:  
Pampoukis   Hellenique Pasteur Institute, 1896 drawing edited, taken from Vladimiros, L. E. (2002): Panagiotis 
Pampoukis, Pioneer Microbiologist - Founder of Hellenique Pasteur Institute, Athens, as cited in Vourtsis A. (2011). 
Available from http://users.uoa.gr/~avourtsi/IPH%20History%202011.pdf 
 i 
 
Abstract 
This dissertation was written as part of the Executive MBA course at the International Hellenic 
University. The study presents a business plan for the establishment of an Anti-rabies Center in 
Thessaloniki. The purpose of this study was to highlight the necessity and feasibility of re-
establishing the institution of the Anti-rabies Center in Central Macedonia region, however adapted 
to current epidemiological data and Greek financial reality by examining the attractiveness of such 
a project from a business perspective.  
The Anti-rabies Center mission, vision and strategy were suggested and analyzed in the present 
dissertation. The methods adopted include literature research, secondary data from the Hellenic 
Center for Disease Control and Prevention (HCDCP) and statistical analysis in order primarily to 
reveal the necessity of this project. Subsequently, a business plan was conducted by using a series 
of business tools and analysis models, designed to assess the strengths and weaknesses of the 
suggested project and demonstrate an achievable timetable in order to prove its feasibility and 
sustainability. The management, marketing and funding were also described resulting in setting an 
effective business plan for the establishment of an Anti-rabies Center in Thessaloniki and 
demonstrating how a potential business opportunity can give birth to a successful provision of 
service.    
The present dissertation was carried out under the supervision of Dr. Korina Katsaliaki, whom I 
would like to acknowledge for her help and support.   
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1. Introduction 
1.1. Authorization  
The present dissertation is an original work prepared as part of the “Executive MBA” 
program offered by the International Hellenic University written by Dr Konstantia E. 
Tasioudi under the supervision of Dr Korina Katsaliaki. All relevant information has been 
collected with full respect of the ethical standards and the rules of research and academic 
integrity. All ideas used and quoted have been properly cited in the text and referenced in 
the bibliography section. The study depicts the practical application of theories and 
concepts instructed during the program to a personal business idea based on secondary 
research. 
 
          30/01/2019  
     Thessaloniki - Greece  
1.2. Background 
Rabies is a zoonotic disease (i.e. transmitted from animals to humans), caused by the 
rabies virus (Lyssavirus genus, Rhabdoviridae family). It is an infectious disease that is almost 
always fatal following the onset of clinical symptoms. It is spread to people through bites or 
scratches, usually via saliva by domestic animals and wildlife. More than 99% of human 
deaths were caused by dog-mediated rabies, especially in developing countries [1]. 
Although the death rate can be lowered substantially by using an effective rabies post-
exposure prophylaxis (PEP), the economic impact of rabies is significant in many developing 
nations where rabies carries a considerable public health burden [2]. 
With the exceptions of Antarctica and Oceania, rabies is endemic on all continents. 
Greece has been rabies-free since 1987 with no human cases since 1970. During 2012 to 
2014, rabies re-emerged in wildlife and domestic animals in northern Greece. The reported 
cases of possible human rabies exposure after domestic, stray or wild animal contact raised 
important public health concerns. The recommendation for administration of human rabies 
PEP consisted of vaccine or vaccine and immunoglobulin, was based on specific criteria. 
Stray dogs were implicated in most cases that resulted in PEP, therefore, interventions to 
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increase the efficacy of prompt collection and evaluation of the animals are urgently needed 
[3]. 
According to World Health Organization (WHO), while deaths from human rabies can be 
averted through PEP, this intervention will never eliminate the disease and costs will only 
escalate over time. A reduction in human mortality due to rabies can be achieved by 
eliminating rabies in dogs, supported by public awareness-raising and improved access to 
timely PEP [1]. 
1.3.  The conceptual framework 
In this study, we report the epidemiology of rabies in Greece over the period from 2012 
to 2018, presenting the rabies situation in animals and describing and analyzing human PEP 
data collected from Hellenic Center for Disease Control and Prevention (HCDCP). Using 
these data, we elaborate on the need for guidelines to limit overuse of rabies biologics after 
exposure in rabies-free areas and to support physicians’ efforts to adjust rabies risk 
assessment in a beneficial way. We aim to achieve that by the establishment of an Anti-
rabies Center in Thessaloniki, which is the city with the second highest density of population 
in Greece as well as high population of stray animals that were implicated in most bites 
required PEP. Furthermore, it is considered a high-risk area and is located in Northern 
Greece where the last rabies epizootic took place. 
1.4. Scope and purpose of the study  
The scope of the present study is to identify the opportunity to set-up a new Anti-rabies 
Center in Thessaloniki, by examining its viability and sustainability, based on the theory and 
the trends by aspiring to fill some of the gaps in the existing managing system of post-
exposure treatment. 
The purpose of this thesis is to outline a business plan for a sustainable Anti-rabies 
Center, by inspecting the current literature including scientific journal papers, online 
databases, websites, laboratory archives and personal communication by conducting 
interviews. This business plan is based on relevant data, examining the probability and the 
factors of its success, its development opportunities, the logistics and risks of its day to day 
activities and its contribution to society over all.  
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The current business plan and all the background analysis are based on specific facts 
and circumstances regarding rabies situation that exists in Thessaloniki. Therefore, it could 
serve as a pilot project that could be applied also in other cities of Greece, taking into 
consideration the local needs and conditions relating to the rabies situation. 
It is also noteworthy that most of the views and opinions expressed in interviews with 
health professionals and veterinarians working in the field of clinical and laboratory 
diagnosis, surveillance, epidemiology and risk management, are largely qualitative and 
subjective. However, they provide a clear insight and understanding of the situation, point 
out the existing gaps in the managing of post exposure treatment and contribute with their 
expertise in making useful remarks and recommendations. 
1.5. Research questions  
The present study focuses on the following research questions: 
Firstly, based on current secondary data provided by the HCDCP, it examines if there is 
enough public interest as well as a necessity to justify the establishment of a pilot Anti-
rabies Center in Thessaloniki.  
Secondly, it examines the current literature in order to identify if similar Anti-rabies 
Centers are established in other countries and what are their activities. 
Third, it aims to verify the possibility to create a well-structured, feasible and 
sustainable plan, by applying a series of proven business analysis models and tools.  
Finally, the largest part of the dissertation deals with the design of an actionable 
business plan for the establishment of an Anti-rabies Center in Thessaloniki, examining its 
conceptual and financial feasibility, the prerequisites and details of its prospective launch, 
the crucial factors of success, as well as its strategic and marketing choices in relation to the 
environment it is going to operate.  
1.6. Contribution and expected outcomes 
 The current study will result in setting an effective business plan for the establishment 
of an Anti-rabies Center in Thessaloniki and will demonstrate how a potential business 
opportunity can give birth to a successful provision of service. The contribution of the 
present dissertation is to review the academic methodologies required to set a 
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comprehensive business plan and evaluate the research related to business planning and 
the potentials as regards to the market into consideration and its dynamics. 
 The following results are expected to arise from the operation of the Anti-rabies 
Center. 
 Anti-rabies treatment free of charge for all patients endangered of rabies according 
to the WHO recommendations; 
 Rational use of anti-rabies vaccine and rabies immunoglobulin (HRIG); 
 Expertise of up to date of doctors and veterinarians cooperating and providing a 
holistic “One Health Approach” to protect and promote public health; 
 Constant surveillance of rabies PEP; 
 Epidemiological and epizootiological surveillance in the country; 
 Increasing public awareness. 
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2. Literature Review  
The initial review of the literature combined general information for rabies, 
epidemiological data, public health care management and a series of business tools and 
analysis models designed to assess the strengths and weaknesses of the suggested business 
plan. The review will describe, summarize, evaluate and clarify this literature by providing 
the theoretical base of the research.  
2.1. Rabies virus and disease 
Rabies is an RNA virus in the genus Lyssavirus of the family Rhabdoviridae that can 
affect all mammals including humans. Transmission occurs from an infected host via bite 
most commonly, but can occur through exposure to mucous membranes, aerosol 
transmission, or exposure in a laboratory setting. Once symptoms of the disease develop, 
rabies is inevitably fatal to both animals and humans. Canine rabies is by far more important 
for public health in the developing world contributing to 99% to the human death causing 
an underestimated number of 59,000 human casualties annually, mainly in Asia and Africa 
[4]. Human-to-human transmission has not been proven. However, some cases of rabies 
transmission through organ transplantation have been described [5]. Direct losses from 
rabies amount to over €4 bn each year [6]. 
An understanding of the epidemiology of this disease is essential in the planning and 
implementation of the most cost-effective control measures. Classical rabies occurs 
registered in over 100 countries. It is in these resource-poor regions, representing more 
than 80% of the world’s population, where canine rabies is endemic and human rabies 
imposes a huge economic burden [7].  
The WHO considers rabies as a neglected disease and efforts are made to succeed wider 
access to appropriate post-exposure treatment for humans. However, rabies is 100% 
preventable - wound cleansing as well as active and passive immunizations by administering 
vaccines and immunoglobulin respectively, as soon as possible after suspect contact with an 
animal and following WHO recommendation. Moreover, dog rabies control by mass 
vaccination campaigns and dog population management are strongly supported and are the 
only way to control the disease [8]. 
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2.2. Rabies situation in Greece 
After 1951 from when recorded rabies data are available, rabies was highly endemic in 
Greece, with a maximum of 13 human cases in 1951 and 1135 animal cases in 1954 [9]. 
After this year, an intense decrease of rabies cases appeared. The last human case was 
reported in 1970 and the last animal case in year 1987 (hunter dog in Evros prefecture, near 
the Turkish borders) [10]. 
While the previous epidemic was dog-mediated, the disease re-emerged in October 2012 
in wildlife and domestic livestock [11]. Forty-eight laboratory confirmed cases, concerned 
mainly foxes (40 foxes, 5 dogs, 1 cat, and 2 cattle) [12] with the last rabies-positive animal 
identified in May 2014. The outbreak of the disease depended upon the situation in 
neighboring countries, all of which had reported animal rabies cases in the years previous 
the outbreak year. Animal rabies cases by species and Regional Units (RUs) in Greece, 2012–
2018 are depicted in Figure 1. 
 
Figure 1: Animal rabies cases by species, RU and year in Greece, 2012–2018 (Virology Laboratory 
archive, Veterinary Center of Athens). 
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Regarding the first Anti-rabies Institute in Greece, its establishment at Athens in 
1896 by the microbiologist Panagiotis Pampoukis was a milestone in the development of 
anti-rabies campaign. The application of anti-rabic treatment resulted in gradually reduce of 
fatality at 0.2%. In the 20th century, six Anti-rabies Institutes which performed laboratory 
testing and anti-rabies treatment were founded by the Greek State [13]. The Rabies State 
Station in Athens was authorized to produce the vaccine for human use. The other Stations 
of the country were performing medical care and post-exposure treatment in humans (free-
of-charge for public servants and the poor) (Appendix A). During 1930 almost 3,000 people 
of whom the vast majority (87%) were bitten by dogs, reportedly received post-exposure 
treatment [14]. 
Anti-rabies Centers were highly appreciated among animal and public health 
professionals in the past. Nevertheless, they were devalued and eventually abandoned in 
the late 2000s. The causes can be found in the public complacency and negligence (despite 
the rabies cases in the Balkans and Turkey), the economic crisis and the ongoing re-
organization of the structures of Public Health as well as regional and local authorities.  
2.3. Rabies situation in Europe 
As seen in Figure 2, available data from 2017 and the first months of 2018 
reported numerous wildlife and domestic animals’ rabies cases, as well as plenty of non-
terrestrial (bat) animal cases. During the same period, five human cases in Russia and 
Ukraine and two imported cases (one in England and one in France) were also recorded. 
The 2017 monitoring data from animals from the eastern European countries showed 
that rabies persisted in sylvatic reservoirs such as foxes (Poland, Hungary and Serbia) and 
was transmitted to dogs (a stray dog in Romania), which are the main source for human 
infection, and to cats (Poland). Also, domestic livestock was infected (two goats in Hungary 
and one cow in Romania). In 2017, thirty-nine bats were found positive by seven Member 
States (Figure 2) [15]. 
These findings demonstrate that the risk of infection for humans remains in Eastern 
Europe and therefore vaccination of people at higher risk of infection should be considered, 
in line with the relevant national and international recommendations [15]. 
 It is noteworthy that rabid animals imported from enzootic areas are reported every 
year in rabies-free areas threatening the rabies-free status of terrestrial animals in western 
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European countries and challenging the public health surveillance system. Surveillance for 
rabies among humans and in domestic animals should be pursued even in countries that 
have successfully eliminated animal rabies as there is a continuous risk of reintroduction of 
the virus via illegally imported rabid companion animals from endemic areas [16]. 
 
 
Figure 2: 2017–2018, rabies cases in Europe, including imported cases. Green circles represent the 
domestic animal cases, red triangles represent the wildlife cases, orange circles are the non-
terrestrial (bat) cases and blue circles represent the human rabies cases (Source: Rabies Bulletin 
Europe, WHO Collaboration Centre for Rabies Surveillance and Research Friedrich-Loeffler Institut).  
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2.4. Post-exposure prophylaxis (PEP) 
Vaccination against rabies is used in two distinct situations: pre-exposure vaccination in 
order to protect those who are at risk of exposure to rabies and PEP to prevent the 
development of clinical rabies after exposure has occurred, usually following the bite of an 
animal suspected of having rabies. 
Same vaccines used for pre-exposure and post-exposure vaccination, but the 
immunization schedule differs. Rabies immunoglobulin is used only for post-exposure 
prophylaxis. Modern vaccines are safer and more effective than the older ones and are now 
available in major urban centers of most countries of the developing world. Rabies 
immunoglobulin, on the other hand, is in short supply worldwide and may not be available, 
even in major urban centers, in many dog rabies-infected countries. PEP using rabies vaccine 
with or without immunoglobulin is highly effective in preventing disease if given correctly 
and promptly after exposure. 
In 2018, WHO has published updated recommendations according to risk category of 
exposure (category I, II and III) and level of rabies risk in the country (high, medium, low) 
with the aim to guide rabies post-exposure management. In Greece, the Ministry of Health 
(MoH) with the cooperation of the HCDCP laid down updated guidelines for the medical 
management of humans potentially exposed to rabies [3]. 
The recommendation for administration of human rabies PEP consisting of vaccine or 
vaccine with immunoglobulin, is based primarily on the geographic area where the incident 
occurred, or the involved animal had lived or visited during the last 6 months before the 
incident, classified as high, medium, or low risk for rabies. An inter-sectorial team, 
comprised of health, veterinary, and wildlife professionals is responsible to perform the risk 
assessment based on veterinary surveillance data, fox ecology, and characteristics such as 
the species of the animal (domestic or wildlife), availability of the animal for veterinary 
observation or laboratory examination, the history of the incident (provoked or unprovoked 
attack) and the category of exposure [3]. 
The treatment should be based on risk assessment and can be divided into three 
categories: i) no risk and therefore no treatment, ii) vaccine only and iii) vaccine and HRIG.  
In all cases, veterinary examination of the animal and laboratory testing, are of 
paramount importance. 
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Public Health of England reports that although treatment should be started promptly, 
initiating rabies PEP is not a medical emergency; most PEP can be administrated the next 
day, apart from head and neck bites, for which PEP treatment should ideally be started 
within 12 hours of reporting [17].  
2.5. Activities of Anti-Rabies Centers in European countries 
The institution of Anti-rabies Center is present nowadays in many countries in Europe 
and worldwide. Anti-rabic institutes are considered nodal centres for the provision of timely 
and appropriate animal bite management to all victims. 
Indicatively, in France, veterinary and human authorities work in close collaboration to 
detect cases and organize the medical responses to rabies, with a territorial network of 96 
veterinary services and 74 Anti-rabies Medical Centers (ARMC) disseminated throughout 
France. ARMC are the only primary care centers allowed to prescribe PEP. For each patient, 
a standard case-report form is systematically filled out describing important epidemiological 
features, such as geographic location, consultation date, type of exposure, animal species, 
contact date with the animal and medical decision concerning PEP. Based on the data 
collected by ARMC, annual reports are written, which describe the patients visiting ARMC 
and those receiving PEP. To comply with the threatened shortage of PEP and ARIG due to 
the cumulative effect of enhanced patient influx and their more frequent prescriptions, a 
specific communication strategy was established for the ARMC network to provide 
information concerning the evolution of the epidemiological situation and to recall the 
indications of PEP. This information was disseminated via the websites of the NRCR, the 
MoH, the National Institute for Health Surveillance and the Ministry of Agriculture [16]. 
In Croatia, the Reference Centre for rabies is performing numerous activities in the area 
of human rabies protection, and therefore cooperates with many veterinary organizations 
and is supervising the anti-rabies activities of county public health institutes in the Republic 
of Croatia. The medical team is performing physical examination of bitten patients, collects 
and records data in the register, keeps and issues patient medical documentation, and 
performs PEP according to indications. Additionally, the employees of the Reference Centre 
are included in numerous professional, teaching and educational activities [18]. 
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3. Methodology 
For the culmination of the present dissertation the author researched and analyzed 
extensively the relevant literature (scientific journal papers, online databases, websites 
etc.).  
Surveillance data on the number of cases of animal rabies and the number of individuals 
undergoing PEP were used to obtain more precise estimates of the burden of disease. 
Furthermore, the economic effects of the disease were estimated from the costs of PEP in 
humans over the period of October 2012 to September 2018. 
Historical data for the number of animal and human rabies cases and number of PEP 
treatments administered which were obtained by numerous references are given in table 1.  
Contemporary data for treatments by scheme (vaccine, immunoglobulin or both) and 
by RU of Hellenic Republic are reported for 51 RUs and abroad from October 19th, 2012 to 
September 30th, 2018. These data were provided by the Department of Epidemiological 
Surveillance and Intervention, HCDCP. Detailed data for gender, age, species and time from 
exposure to evaluation, were available from October 2012 to December 2016 [19]. Data are 
presented in stacked column charts, pie charts and boxplot diagrams.  
PEP rate represents the number of regimens per 100,000 residents per annum. 
Population data are taken from the 2011 Population Census revision by Hellenic Statistical 
Authority [20]. Demographics of the people administered with PEP are given with 
descriptive statistics. When needed, values and percentages of demographics, as well as the 
time from exposure to evaluation are given with their respective 95% exact confidence 
intervals. Geographic Information System (GIS) maps present the administrative division of 
Greek territory and the spatial distribution of rabies cases, grouping of RUs by estimated risk 
and PEP per RU. 
GIS maps were created with QGIS Geographic Information System 3.0.2 'Girona' (QGIS 
Development Team, 2018, Open Source Geospatial Foundation Project). Stakeholder matrix 
was designed in Edraw Max 7.7 (Edrawsoft, 2014). Work-breakdown structure was created 
with WBS Chart Pro 4.9 (Critical Tools, Inc., 2012) and Gantt Chart with ProjectLibre version 
1.7.0 (ProjectLibre Inc., 2015). Statistical analysis was carried out in Microsoft Office Excel 
2007 (Microsoft Corp., 2007). 
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Moreover, 12 interviews with human health professionals and veterinarians who are 
actively involved in the management or diagnosis of the disease were utilized to develop a 
more comprehensive methodology. The interview consisted of 17 questions (Appendix B). In 
detail, the interviewees were:  
- one medical doctor, Department of Epidemiological Surveillance and Intervention, 
HCDCP; 
- one veterinarian, Department of Epidemiological Surveillance and Intervention, 
HCDCP; 
- one nurse, Department of Epidemiological Surveillance and Intervention, HCDCP; 
- two veterinarians, Department of Zoonoses, MRDF;  
- three veterinarians, National Reference Laboratory (NRL) for rabies in animals;  
- one veterinarian, Veterinary Directorate, RU of Thessaloniki;  
- one veterinarian who had worked in the Anti-rabic Unit in Athens;  
- one medical doctor who had worked in the Anti-rabic Unit in the Special Diseases 
Hospital of Thessaloniki (Infectious Diseases); and  
- the former Director of WHO – Mediterranean Zoonoses Control Centre.   
Furthermore, a personal communication with the veterinarian working in the Anti-rabic 
unit in the Special Diseases Hospital of Thessaloniki (Infectious Diseases) and later in 
General Hospital of Thessaloniki “George Papanikolaou” was undertaken.  
All interviews were conducted between December 2018 and January 2019. Most of 
them (10/12) conducted in person, taking one hour on average, and the remaining ones 
(2/12) conducted by telephone. Subsequently, a content analysis was performed including 
analysis of data obtained from the interviews, formulation of codes and creation of 
categories and themes (Results section). All ideas were recorded and were taken into 
consideration in the development of the business plan. However, the opinion of most 
interviewees was not necessarily used (e.g., in the organizational chart of the Anti-rabies 
Center), instead an ideal solution was selected based on the cost management analysis. 
All the above data have been further analyzed in order to deepen the understanding of 
the topic and form the context on which then the business plan has been developed. 
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4. Results 
4.1. Post-exposure prophylaxis: number per year, RU, type, PEP rate 
Number of animal and human rabies cases, along with initiated rabies PEP from 1951 to 
2018 are summarized in Table 1 [21-25, 14 and data provided by HCDCP for the period 
1/10/2012 – 30/09/2018]. No data were available for the period 1998–2011. 
 
Table 1: Number of rabies PEP, animal and human rabies cases by time periods.  
 
1951–
1955 
1956–
1960 
1961–
1965 
1966–
1970 
1971–
1975 
1976–
1980 
1981–
1987 
1988–
1992 
1993–
1997 
1998–
2011 
1/10/2012–
30/09/2018 
PEP 46,786 51,735 41,989 25,699 17,415 10,788 25,000 8,363 3,804 n/a 1,873 
Animal 
rabies 
cases 
4,720 3,906 2,184 827 209 33 7 0 0 0 48 
Human 
rabies 
cases 
37 16 5 2 0 0 0 0 0 0 0 
 
Hellenic Republic territory is divided in 13 administrative Regions and 74 RUs (Figures 3 
and 8). Figure 3 shows the location where rabies cases were reported from October 2012 to 
the last one in May 2014. Greek RUs are divided by estimated risk for rabies circulation in 
three categories. Oral rabies vaccination (ORV) campaigns of red foxes exclusively included 
RUs with medium and high estimated risk of rabies circulation (Figure 3). The first three 
ORVs covered 24 RUs, while the fourth campaign covered 21 RUs in central, north-western 
and northern Greece. Since 5th ORV campaign, the three north-eastern RUs (Xanthi, Rodopi, 
Evros) are included, due to the epizootiological situation of the disease in neighboring 
Turkey. Some specific areas were excepted (Thasos Island, Sporades islands, part of 
Fthiotida and the largest part of Etoloakarnania).  
 - 14 - 
 
 
Figure 3: Rabies cases in Greek territory during 2012–2018 and division of RUs by estimated risk for 
rabies circulation and average PEP rate (number of post-exposure prophylaxis per 100,000 
residents). All rabies cases were reported from October 2012 to May 2014. 
 
The average PEP rate is 4.0 and 11.1 for the whole of Greece and for rabies affected 
areas respectively [3]. RUs with the highest PEP rates are with high and medium estimated 
risk (Figure 3). 
Figure 4 presents the number of PEP by RU and by scheme during 2012–2018. 
Thessaloniki is depicted to have the highest number of PEP following by Larisa and Ioannina. 
Pie chart of Figure 5 graphically presents the number of administered treatments divided by 
scheme; in the line chart of Figure 6 the total number of PEP treatment in Greece by type 
and by year are presented. Finally, Figure 7 includes a line chart for the total number of PEP 
treatment per year in Greece (including 22 regimens initiated abroad) from October 19th, 
2012 to September 30th, 2018. 
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Figure 4: Stacked column chart with the number of PEP by RU and scheme from October 19th, 2012 
to September 30th, 2018. 
 
 
 
Figure 5: Pie chart of the number of PEP by scheme from October 19th, 2012 to September 30th, 
2018. 
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Figure 6: Line chart of total number of PEP treatment per type and per year in Greece (including 22 
regimens initiated abroad) from October 19th, 2012 to September 30th, 2018. 
 
 
Figure 7: Line chart of total number of PEP treatment per year in Greece (including 22 regimens 
initiated abroad) from October 19th, 2012 to September 30th, 2018. 
 
Central Macedonia is one of the thirteen administrative Regions of Greece. With a 
population of almost 1.9 million, it is the second most populous Regions in Greece after 
Attica and represents the 17% of population of Greece. The Region is divided into seven 
RUs: Chalkidiki, Imathia, Kilkis, Pella, Pieria, Serres and Thessaloniki. Central Macedonia is 
Greece's most visited Region and accounts for 18.2% of the total tourist flow in the country 
[26]. Thessaloniki RU is in the middle of Region and is the most populous Greek RU. 
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Figure 8: Central Macedonia Region and capital cities. 
 
PEP ratios in the seven RUs of Central Macedonia are among the highest in Greece 
(Figure 3). As seen in Figure 9, almost half PEP regimens were administrated in Central 
Macedonia Region. Figure 10 presents the number of PEP treatments per year in Central 
Macedonia Region, while Figure 11 additionally divides them by scheme. Approximately one 
fourth of all PEP has been demonstrated in Thessaloniki RU (data provided by HCDCP). 
  
 
Figure 9: Pie of pie chart with the percentages of rabies post-exposure prophylaxis by Region due to 
exposure to animals, Greece, October 19th, 2012 to September 30th, 2018.  
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Figure 10: Line chart with the number of PEP treatments per year in Central Macedonia Region, 
October 19th, 2012 to September 30th, 2018. 
 
 
Figure 11: Line chart with the number of PEP treatments per year and by RU of Central Macedonia, 
October 19th, 2012 to September 30th, 2018. 
 
It is noteworthy to point out that if the highest average PEP rate reported in Greece (RU 
Ioannina) occurred in Central Macedonia Region, this would mean a threefold increase in 
the number of PEP administrations. 
4.2. Time from exposure to evaluation 
A median of 2.0 hours elapsed from the exposure until evaluation from a medical 
practitioner (n = 1173, avg = 21.3, CI 95%:18.8–23.8, range: 0–397) with 77.0% of cases 
presenting at a healthcare setting during the first 24 hours [3]. Figure 12 presents the 
boxplots of time interval between exposure and presentation in hospital by WHO category 
of exposure. 
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Figure 12: Boxplot diagram for time elapsed from exposure until presentation to a hospital by WHO 
category of exposure, Greece 2012–2017. Source: Dougas et al., 2018 [19]. 
 
4.3. Species 
As shown in Figure 13, exposure to ownerless dogs was reported in most incidents 
where PEP was used, followed by companion dogs, ownerless cats, foxes, bats and other 
animal species [19]. 
 
Figure 13: Pie of pie chart of animal species reported in incidents where PEP was used, Greece 2012–
2018. 
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4.4. Estimated cost of PEP 
Active immunization is achieved by cell-culture vaccines administration as 
recommended by the WHO. The five-dose regimen for post-exposure treatment is 
administered on days 0, 3, 7, 14 and 21 or 28 intramuscularly. The cost of vaccine 
(Verorab®) used is 27.36 €, excluding VAT.  
Passive immunization is achieved by human rabies immunoglobulin administration 
(Berirab®). The recommended dose of HRIG is 20 IU/kg body weight therefore the mean 
required dose for an adult consists of 2 bottles. The cost of 1 bottle of BERIRAB INJ. SOL. 750 
IU/AMP - BT x 1AMP x 5ML is estimated to be 505.69 €, excluding VAT. HRIG should be 
administered on the same day as the first dose of vaccine and no later than day 7. There are 
specified requirements regarding the administration techniques and the anatomical site of 
infusions. 
Figure 14 demonstrates a line chart with the total cost of PEP treatment administered in 
Central Macedonia per year (from 19th October 2012 to 31st September 2018). The total cost 
of the vaccines and HRIG administered in all seven RUs of Central Macedonia during the 
period January 1st to September 30th, 2018 was estimated to be 75,867.60 €, VAT excluded 
(Table 2).  
 
 
Figure 14: Line chart with the total cost of PEP treatment administrated in Central Macedonia per 
year, 2012–2018. 
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Table 2: Number of treatments per scheme administrated in Central Macedonia Region from 
January 1st to September 30th, 2018. 
Central Macedonia Vaccine 
Vaccine & 
HRIG
1
 
HRIG
1
 Total 
RU Thessaloniki 28 51 2  
RU Imathia 0 1 0  
RU Pieria 1 0 0  
RU Pella 14 4 0  
RU Kilkis 2 0 0  
RU Serres 0 1 0  
RU Chalkidiki 8 1 0  
Total  53 58 2 113 
Cost (€)
2
    per dose 
            
                    per PEP treatment
3
 
 
                    Total cost  
 
27.36 
 
136.8 
 
7,250.4 
533.05 
 
1,148.18 
 
66,594.44 
505.69 
 
1,011.38 
 
2,022.76 
 
 
 
 
75,867.60 
1. HRIG:  Human Rabies Immune Globulin 
2. Cost values VAT excluded 
3. PEP treatment includes 5 vaccine doses or 2 HRIG doses or both 
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4.5. Interview results 
A content analysis was performed including analysis of data obtained from the 
interviews, formulation of codes, creation of categories and five themes. These are 
presented in the following tables (Tables 3–7). 
 
Table 3: Reasons for abandonment of the Anti-rabic institution — Problems in the management of 
human biting incidents 
1
st
 Theme Reasons for abandonment of the Anti-rabic institution — Problems in the management 
of human biting incidents during the last rabies epizootic 
Categories Reasons 
 Complacency, indifference, 25 years without rabies cases from the last epizootic (11) 
 Not a priority (6) 
 Economic crisis (6) 
 
Problems 
 Panic and fear of people bitten (4) 
 Difficult coordination of all the stakeholders (4) 
 Insufficient information to the public as to where they should address (4) 
 High number of stray animals (4) 
 
 
Complacency, indifference and absence of rabies cases, were mentioned as the main 
reasons for the abandonment of the Anti-rabic institution by the majority (11/12) of the 
interviewees. Lack of priority as well as the economic crisis were also reported by half. The 
main problems in the management of human biting cases were the fear and the panic of 
people bitten, who in most of the cases didn’t have adequate information regarding rabies. 
The difficulty in the coordination of all the stakeholders involved, along with the high 
number of stray animals were also reported by 4 out of 12 of the interviewees (Table 3). 
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Table 4: Need to create an Anti-rabies Center – Location – Structure 
2
nd
 Theme Need to create an Anti-rabies Center – Location – Structure 
Categories  There is a need to set up an Anti-Rabies Centre (12) 
 Thessaloniki is the right place to establish the Antri-rabies Centre (12) 
 It could be an autonomous unit but integrated into the Hospital (11) 
 It could serve the RUs of Central Macedonia Region (11) 
 
 
All interviewees agreed that there is a need for the establishment of an Anti-rabies 
Center and Thessaloniki is the first-choice place to do that. Most of them (11/12) suggested 
the Center to be integrated in the premises of a hospital serving all the RUs of Central 
Macedonia Region (Table 4). 
 
Table 5: Personnel of Anti-rabies Center 
3
rd
 Theme Personnel of Anti-rabies Center 
Categories  The coexistence and collaboration of medical doctor and veterinarian could provide a 
holistic “One Health Approach” to protect and promote public health (12)  
 Medical doctor (12), vet (12), administrative employee (11), animal worker (9), driver 
(7), nurse (5)  
 Staff visits away from the Anti-rabies Center would be feasible for the veterinarians in 
special occasions (7)  
 
 
All interviewees underlined the necessity of the coexistence and collaboration between 
the doctor and the vet in providing a holistic approach to protect public health. Moreover, 
four additional specialties were suggested: administrative employee (11/12), animal worker 
(9/12), driver (7/12) and nurse (5/12) for the operation of the Center. Regarding staff visits 
away from the Center, 7/12 interviewees suggested that to be feasible only for the vets in 
special occasions (Table 5). 
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Table 6: Responsibilities – Marketing of the Anti-rabies Center 
4th Theme 
 
 Responsibilities – Marketing of the Anti-rabies Center 
 
Categories  Case assessment by medical doctor and vet (12) 
 Advisory, informative, educational role (12) 
 Restricted facility for animal care and hospitalization during the 15 days observation 
period (10) 
 8 hours a day for 7 days a week, but available 24/7 on call (3)  
 Advertising in TV, radio, newspapers (12) 
 Posters (7) 
 Press release, circulars & e-mails to the Competent Authorities (7) 
 
 
Regarding the responsibilities of the Anti-rabies Center, all interviewees agreed that the case 
assessment should be performed by the collaboration and coexistence of a medical doctor and a 
veterinarian. Its role should additionally be mainly advisory, informative as well as educational. A 
restricted facility for animal hospitalization during the 15 days observation period was proposed by 
most interviewees. Advertising in the media (television, radio, newspapers) was suggested by all 
interviewees as the most effective way to make the Center known to the public (Table 6).  
 
 
Table 7: Contribution and difficulties in the establishment of the Anti-rabies Center 
5
th 
Theme Contribution and difficulties in the establishment of the Anti-rabies Center 
 
Categories  Raising awareness and informing the public and health professionals (8) 
 Better management of human bites (6) 
 Management by qualified personnel (4) 
 Reduced possibility of under- or over-estimation of the incidents (4) 
 Reduce workload in hospitals and public health and veterinary Services resulting in 
better management of other incidents (4)  
 Cost during economic crisis (12) 
 Lack of legal basis / existing legal framework / bureaucratic procedures (7) 
 Lack of political will (6) 
 
 
Most of the interviewees (8/12) reported that the establishment of the Anti-rabies 
Center will contribute to the public as well as health professional’s awareness regarding 
rabies, while half of them agreed that there will be better management of human bites. 
Thirty three percent of the interviewees expressed the opinion that the management of 
human bites will be done by qualified personnel reducing the possibility of under- or over-
estimation of the incidents and reducing the workload from other health facilities. The cost 
due to economic crisis, the lack of legal basis and the lack of political will were reported as 
the main difficulties that could hamper the initiative (Table 7). 
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5. Data analysis and interpretation of results 
Literature review provides an insight of the Europe and Greece rabies status concluding 
to the following observations: 
- Once symptoms of the disease develop, rabies is inevitably fatal. 
- Rabies is 100% preventable by wound cleansing and administering vaccines and 
immunoglobulin, after suspect contact with an animal following WHO 
recommendation. 
- The risk of humans’ infection remains in Eastern Europe and therefore vaccination of 
people at higher risk of infection should be considered [15].  
- Continued monitoring of rabies is necessary in target animals in wildlife and in 
domestic animals. 
- Rabid animals imported from enzootic areas are reported every year in rabies-free 
areas, challenging the public health surveillance system. 
- The disease re-emerged in Greece in October 2012. The country has not yet been 
declared as non-rabies free. Numerous cases in Turkey’s coastline. 
- Anti-Rabies Centers in Greece were highly appreciated among health professionals in 
the past. They were devalued and eventually abandoned in the late 2000s, due to 
public complacency, economic crisis and ongoing reorganization of the structures of 
Public Health and local authorities.  
- Zoonoses have always been an area of interest and, of these, rabies provides an 
example of the benefits of a One Health approach. 
Furthermore, surveillance data for the number of PEP treatments administered during 
the period October 19th, 2012 to September 30th, 2018 were provided by the Department 
of Epidemiological Surveillance and Intervention, HCDCP. 
The following outcomes can be derived from the above data analysis: 
- High average PEP rate in RUs with high estimated risk and rabies affected area. 
- Number of initiated PEP treatments descending but still to be reckoned with. 
- Number of PEP initiated was slightly raised in Greece in 2017 and 2018 years; it was 
significantly raised in Central Macedonia Region in 2018 and specifically in 
Thessaloniki RU. 
- High-cost immunoglobulin initiated in half cases.  
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- Central Macedonia Region represents the 17% of population of Greece and is Greece 
most visited Region. 
- PEP ratios in RUs of Central Macedonia are among the highest in Greece. 47% of all 
PEP was administrated in Central Macedonia. 
- One fourth of all PEP has been demonstrated in Thessaloniki RU. 
- A median of 2 hours elapsed from the exposure until evaluation from a medical 
practitioner. 77% of cases presented at a healthcare setting during the first 24 h. 
- 67% of PEP used was due to exposure to ownerless dogs. 
- The mean total cost of the vaccines and HRIG administered in all seven RUs of 
Central Macedonia during the period 2012–2018 was estimated to be 67,892.92 €, 
while only for the first nine months of 2018 was estimated to be 75,867.60 €, VAT 
excluded. 
From the interviews’ analysis the following outcomes can be derived: 
- The reappearance of rabies revealed problems in managing human biting incidents. 
- There is a necessity for the establishment of an Anti-rabies Center nowadays. 
- Thessaloniki is an ideal choice for the establishment of the first pilot Anti-rabies 
Center covering the needs of the RUs of Central Macedonia Region. 
- The Anti-rabies Center could be an integrated unit in the hospital premises. 
- The collaboration and communication between physicians and veterinarians are of 
paramount importance for the successful management of animal bites. 
- The contribution of the Anti-rabies Center would be the following: 
 Better and prompt evaluation of animal bites. 
 Rational use of anti-rabies vaccines and HRIG. 
 Reduced workload for medical personnel in hospitals and public Health 
Directorates. 
 Public awareness.  
- The causes that would hinder this endeavor would be the following: 
 Cost. 
 Complacency. 
 Lack of priority. 
 Lack of political will. 
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6. Business Plan 
6.1. Company description 
6.1.1. Trade Name 
A proposed trade name could be “Anti-rabies Center of Central Macedonia” with 
abbreviation being “ACCM” and the corresponding Greek name “Αντιλυσσικό Κέντρο 
Κεντρικής Μακεδονίας”. 
 
6.1.2. Vision and Mission Statements  
6.1.2.1 Vision statement 
“One Health approach for a safe, cost effective and direct access to rabies post-exposure 
treatment aiming to benefit society”. 
 
6.1.2.2 Mission statement 
Our mission is to be among Europe’s best Anti-rabies Centers in class meaning:  
- Human and animal health professionals cooperate and provide a holistic “One 
Health Approach” to protect and promote public and animal health. 
- Quality and on-time evaluation of a human bite by an animal suspected to be rabid 
and accidental exposures to oral rabies vaccines. 
- Rational use of anti-rabies vaccines and HRIG. 
- Professional expertise and commitment to public needs seeking for rabies post-
exposure treatment. 
- Continuous training and capacity building of the personnel.  
- Advocacy, communication and social mobilization; value to citizens. 
- Intensifying dialogue with the stakeholders. 
- European collaboration and a strong international position. 
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6.1.3. Principles of operation 
The ACCM should  
i. provide timely access, free of charge, safe and effective anti-rabies treatment 
(vaccines and HRIG); 
ii. follow guidelines recommended by WHO and accurately categorize the incidence 
according to risk category of exposure (category I, II and III) and level of rabies risk of 
the area (high, medium, low);  
iii. provide privacy and psychological support for the people seeking for PEP;  
iv. provide information for the disease and the country’s eradication program, including 
pet travel scheme and wildlife oral vaccination; 
v. be equipped to provide quality and safe PEP (refrigerator, vaccines, HRIG, 
detergents, water supply, waste disposal, record keeping etc.);  
vi. be staffed by trained doctors, veterinarians, nurses and administrative employees; 
vii. ensure the continuous training of the staff;  
viii. maintain a detailed and updated bite exposure registry; 
ix. collaborate with the other health organizations.  
The opening hours of the ACCM will be 8 hours per day, 6 days a week (Monday–
Saturday) and the medical doctor and the two veterinarians will be on call duty, 24 hours, 
ten days per month each. 
 
6.1.4. Location 
All interviewees agreed that Thessaloniki is the best choice to establish the first Anti-
rabies Center. Most of them (~70%) believe it would serve humans bitten in the Region of 
Central Macedonia. The choice of Thessaloniki is ideal due to the following reasons: 
- Central Macedonia is the second most populous region in Greece and represents the 
17% of population in Greece. It is Greece's most visited region and accounts for 18.2% 
of the total tourist flow in the country [26]. It consists of seven RUs of high estimated 
risk for rabies. Moreover, all seven RUs participated in the oral rabies vaccination 
campaigns of wildlife that have been carried out. 
- RU of Thessaloniki is in the middle of the Central Macedonia Region and is the most 
populous Greek RU. 
 - 29 - 
 
- Thessaloniki has many stray animals which were implicated in most incidents that 
resulted in PEP.   
- In the recent rabies epizootic, the introduction of the disease in animals came from the 
northern neighboring countries. 
- Rabies cases are reported in Turkey, which shares borders by land with the northern 
Greece. 
- Most rabies cases during the last rabies epizootic reported in the northern territory of 
Greece. 
- Almost half PEP regimens were administrated in Central Macedonia Region during the 
period October 19th, 2012 to September 30th, 2018; approximately one fourth of all 
PEP has been demonstrated in Thessaloniki RU at the same period.  
- Number of PEP initiated was slightly raised in Greece in 2017 and 2018 years; it was 
significantly raised in Central Macedonia Region in 2018 and specifically in Thessaloniki 
RU. 
The General Hospital of Thessaloniki “George Papanikolaou” is selected to establish the 
ACCM in its premises. With this view agreed 92% of the interviewees for the following 
reasons: 
- The Hospital has been designated as the Reference Hospital for rabies out of five in 
Greece, covering the 3rd and 4th Regional Health Authority of Macedonia and Thrace 
(YPE). Therefore, it is staffed with health professionals informed about rabies. 
- Moreover, the hospital is already equipped with facilities for storing the vaccines and 
HRIG, which are then forwarded to other hospitals and Directorates of Public Health in 
the area. 
- People bitten by animals could have access to the emergency unit of the hospital, if 
required. 
- To reduce the operational cost. 
- Adequate parking. 
- Large areas to accommodate ACCM flow such as areas for registration, examination 
room and offices. 
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6.1.5. Ownership structure/legal entity 
In Greece, infrastructure for public services including hospitals has been constructed, 
operated and maintained by the public sector and financed through public budget 
appropriation. Healthcare in Greece is provided by the state and more specifically by the 
National Healthcare Service (Greek acronym ESY). Regional health authorities coordinate 
the health services on a regional level, with the administrator appointed by the MoH.  
Most interviewees proposed that the ACCM should be integrated in the General 
Hospital of Thessaloniki “George Papanikolaou” which is under the public legal entity. Under 
the umbrella of the public entity would be a greater transparency to the public of many 
aspects of the ACCM’s activities. 
This public legal entity will be supervised by MoH in order to address and monitor, 
coordinate and assist of actions to provide efficient, safe and direct access to rabies PEP. 
ACCM will be subsidized by the regular budget of the MoH, from the Public Investment 
Program, as well as from European Union (EU) funding. 
A Presidential Decree, will be issued on a proposal by the Ministers of the Presidency of 
the Government, Finance and Health, specifying the subject and the specific responsibilities 
of the ACCM in the context of its purpose, its administration and its control, the 
management of the Center, the staff and its organization, its general function and all other 
relevant details. 
 
6.1.6. Stakeholder’s matrix 
The stakeholder’s analysis is an important process that helps to identify stakeholder’s 
interest for the project, the negative stakeholders that would potentially have negative 
effect on the project and ways to influence positively other stakeholders. Rabies is a very 
good exemplar where the stakeholder’s matrix could be applied given that rabies 
management requires a multi-sectoral collaboration and coordination. Stakeholder’s matrix 
is a way to plot stakeholders by power on the y axis and interest on the x axis (Figure 15). 
 - 31 - 
 
 
Figure 15: Stakeholder’s matrix for ACCM  
 
Figure 15 depicts a stakeholder’s matrix divided in four quadrants presenting the power 
and the interest for each stakeholder in relation to the purpose of the project. As shown in 
the figure, the power and interest are high for the community and the suppliers of vaccines 
meaning that they could influence the project in a positive way. Additionally, the patients, 
HCDCP, hospitals, Directorates for Public Health, the Greek NRL for rabies in animals and 
Veterinarian Authorities consider the project to be important but their influence on the 
success of the project is quite low. On the other hand, the interest of MoH and MRDF 
doesn’t closely coincide with the aims of the project, even though they have a great power. 
The stakeholder’s matrix is used to identify and build relationships among stakeholders, 
since collaboration is critical for bringing project success.  
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6.1.7. Company’s Strategy (SWOT Matrix) 
The SWOT Matrix is an important matching tool that helps managers develop four types 
of strategies: SO (strengths-opportunities), WO (weaknesses-opportunities), ST (strengths-
threats) and WT (weaknesses-threats) strategies. Matching key external and internal factors 
is the most difficult part of developing a SWOT Matrix and good judgment is required. The 
SWOT Matrix for the ACCM is presented in Table 8 below. 
Among the suggested strategies, the following five seems to be more attractive than 
the others: S1-O3, S2-O4, S3-O5, S6-T8 and W6-T8. Overall the strengths and opportunities 
outweigh the weaknesses and threats in this endeavour. Thessaloniki is defined as a 
strategic location for the establishment of the first pilot Anti-rabies Center in Greece, 
serving people from Central Macedonia Region where the demand for PEP is high. The key 
element is the provision of a safe and cost-effective PEP by physicians and vets, experts in 
their field, leading to the rational use of PEP. Additionally, the integration of the ACCM in 
the hospital premises and the fact that it is addressed to people from the whole Central 
Macedonia Region, would balance the increased pressure to reduce healthcare costs. All the 
above are in agreement with the majority of the interviewees, whose views have been 
taken into account in the design of the strategy.  
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Table 8: SWOT Matrix for ACCM 
SWOT MATRIX 
INTERNAL 
Strengths (S) 
 
1. Strategic location 
2. Collaboration between physician and vet 
3. Highly qualified staff/expertise 
4. Specialized trainings of its personnel for 
upgrading skills 
5. Better evaluation of human bites 
6. Integration in the hospital premises 
7. Patients visiting the hospital daily could 
be aware of the Center 
8. Provision of quality of service and 
psycho-emotional comfort 
9. 24/7 on call service 
10. Adds value to rabies preparedness 
Weaknesses (W) 
 
1. Investment cost 
2. Lack of clarity on the impact of 
Anti-rabies center activities to the 
public 
3. Lack of a well-designed website 
4. Lack of an area that could serve 
as examination room for animals 
5. Lack of an Information Desk in 
the entrance of the hospital 
directing people 
6. ACCM will serve people from 
long distances throughout the 
Central Macedonia Region 
E
X
T
E
R
N
A
L
 
Opportunities (O) 
 
1. Greece lost rabies-free status 
2. Social mobilization 
3. Increasing demand for PEP 
4. Non-rational use of PEP 
5. No provision of PEP by experts 
6. Absence of Anti-rabies Centers in 
Greece 
7. Neighboring countries report rabies 
cases 
8. Collaboration among human and 
animal health professionals 
9. Increased migratory wave 
10. Increased number of tourists 
11. Provision of funds for worldwide 
zoonotic diseases 
12. General reforms to the National 
health system take place 
(restructuring etc.)  
13. Oral rabies vaccination of red foxes 
and awareness campaigns. 
S-O Strategies 
 
S1-O3: Located in Thessaloniki providing 
services to people bitten in Central 
Macedonia Region where the demand for 
PEP is high 
 
S2-O4: Rational use of PEP by the 
collaboration between the physicians and vets 
 
S3-O5: Provision of a safe and cost-effective 
PEP by experts 
 
S4-O5: Training of the staff on proper post 
exposure management 
 
S9-O11: To mobilize resources to support the 
operation of the 24/7 on call service  
 
S6-O12: General reforms to the National 
health system take place that could allow the 
integration of the ACCM in the hospital 
premises 
W-O Strategies 
 
W2-O8: The collaboration between 
human and animal health 
professionals would make the 
activities of the ACCM known to 
the public 
 
W3-O11: Allocation of funds for a 
well-designed website 
 
W4-O11: Allocation of funds to 
construct an examination room for 
animal 
 
W5-O3: Placing an Information 
Desk in the entrance of the hospital 
to direct the people looking for PEP 
Threats (T) 
 
1. Lack of funding to cover the 
training of personnel in Institute 
Pasteur (Paris) 
2. Legal impediment to include a 
facility inside the hospital to serve 
as an examination room for animals 
3. Rabies management is a multi-
sectoral task making collaboration 
and coordination among 
stakeholders difficult to achieve 
4. Lack of funding sources 
5. Lack of political will 
6. Rabies is low in priority list 
7. Compliance due to the absence of 
rabies cases for almost 5 years 
8. Pressure to reduce healthcare costs 
9. Reflux of people to other hospitals 
in the country 
 
S-T Strategies 
 
S3-T9: The highly qualified staff of the 
ACCM could reduce the reflux of people to 
other hospitals and Directorates of Public 
Health, resulting in a reduction of the 
workload of these health care services 
 
S6-T1: The knowledge gap could be 
temporarily covered by health professionals 
of the hospital, who are already informed 
about rabies 
 
S6-T8:  The establishment of the ACCM in 
the hospital premises could reduce operating 
costs balancing the increased pressure to 
reduce healthcare costs 
 
 
 
W-T Strategies 
 
W4-T2: Contact the legal 
department of MoH to make the 
necessary modifications to the 
existing legal framework 
 
W6-T8: The ACCM would serve 
people throughout the Central 
Macedonia Region balancing the 
pressure to reduce healthcare costs 
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6.2. Market, industry and competitor analysis 
6.2.1. Market (PEST) analysis  
 The external environment analysis or PEST analysis is a measurement tool that is used 
to assess markets for a product or business service at a given time frame. ‘PEST’ stands 
mainly for Political, Economic, Social, and Technological factors. It helps organizations take 
better business decisions and improve efficiency by studying various factors which might 
influence a business. PEST analysis for the ACCM is presented below. 
 
6.2.1.1 Demographics 
From the total of people received PEP treatment in Greece during the period November 
2012 – December 2017, 63.2% were males [19]. The range of age of people treated with PEP 
was from 1 to 90 years (CI 95%: 39.1–41.2 years), with a mean age of 40.2 years and median 
equal to 39.0 years [3].  
 
6.2.1.2 Political factors 
- General reforms to the National health system take place, including reduction of the 
specialist units that could affect negatively the establishment of the ACCM. 
- Large numbers of refugees (peaking at 1 million in 2015) coming to Greece are entitled to 
access emergency services for the treatment of life-threatening conditions [27]. Τhis 
would increase the influx of patients to the ACCM. 
- Political agendas affect fund allocation to healthcare. As healthcare costs rise, 
policymakers focus on effective methods to control costs and divide up limited budgets 
for healthcare which would influence negatively the initiative. 
- Inefficient bureaucracy may hamper the initiative. 
- Lack of political will. 
- High dependence on EU, Structural Funds. 
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6.2.1.3 Economic factors 
- Current unsteady financial landscape further decreases government spending. 
- In the context of cost containment, there is a pressure to reduce training and 
administrative budget since they are considered costly and non-core. 
- Significant economic burden of rabies, including human mortality. Indicatively, the canine 
rabies worldwide costs $4,000 million annually, $500 million on PEP, $160 million on dog 
vaccination and $800 million livestock losses [6]. 
- High cost of PEP treatment. Inadequate supply of rabies vaccines and HRIG. 
- Companies can benefit from EU funding. Social care businesses have priority in EU 
funding over private companies. 
 
6.2.1.4 Social-cultural factors 
- Large number of people looking for PEP treatment after an animal bite. 
- Lack of education, information and awareness in the general population regarding rabies 
prophylaxis. 
- Low competencies in a proportion of primary care doctors to evaluate incidents of 
humans exposed to potentially rabid animals. 
- A necessity to establish the “One Health approach” for a successful management of 
rabies through collaboration between human and animal health sectors. 
- Huge social cost in case of a human death from rabies. 
- Social mobilization to increase public awareness. 
- Lack of culture for adequate sharing of surveillance rabies data between human and 
animal sectors at both local and national level. 
 
6.2.1.5 Technological factors 
- Use of technology for proper and complete data management and sharing with other 
stakeholders, establishing a national shared database for rabies containing surveillance, 
epidemiological and laboratory data.  
- Use of technology (webpages, news websites, social media) for marketing and public 
awareness, service, communicating and training. 
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- Establishment of a 24/7 on call service to improve reporting of animal bites and to 
provide first aid instructions. 
- Well designed and informative website. 
 
6.2.1.6 Environmental factors 
- Safe waste disposal: sharps (needles, vaccines and HRIG vials), pathological, 
pharmaceutical and chemical wastes are properly segregated in color bins and disposed 
according to safe disposal practices. 
 
6.2.2. Industry analysis 
Apart from the market analysis, an analysis of the industry can by performed by using 
the Porter’s Five Forces Model. It is a framework that analyzes the level of competition 
within an industry and plays a key role in building competitive advantage for the company 
and maximization of its profit. 
ACCM will be a mission-driven social Center aiming to provide efficient, safe and direct 
access to rabies post-exposure treatment. Therefore, maximization of profit is not an 
objective and the Porter’s Five Forces model cannot be applied. 
 
6.2.3. Competitors analysis 
As potential competitors could be defined the hospitals that evaluate and provide PEP 
treatment (first dose of vaccine and HRIG, if required) and the Directorates of Public Health 
which belong to the MoH, where the vaccination scheme is completed. Moreover, HCDCP 
keeps records of epidemiological data for rabies and provides guidance to healthcare 
professional and the public. The establishment of the ACCM will have the following 
advantages over its potential competitors: 
- Holistic approach for the evaluation of the animal bite cases (collaboration between 
physician and veterinarian). 
- Better evaluation and category characterization of animal bites and accidental 
exposures to oral rabies vaccines. 
- Expertise/training of personnel. 
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- Efficient, safe and direct access to post-exposure treatment.  
- Rational use of vaccines and HRIG. 
- Great social impact and benefit to the society. 
 
6.3. Marketing plan 
The Company’s Marketing Plan is consisting from the Marketing Analysis (the 5 C’s) and 
Marketing Mix (the 4 P’s). 
 
6.3.1. Marketing analysis  
6.3.1.1 Customers 
Customers will be the people that have been exposed to a potential rabid animal in the 
Central Macedonia Region and they are seeking for information about the need for post-
exposure treatment. 
 
6.3.1.2 Company 
Situated in Thessaloniki, the Center with the trade name “Anti-rabies Center of Central 
Macedonia” (ACCM) will provide effective, safe and direct access for rabies post exposure 
treatment to every person in need in the Region of Central Macedonia. Once awareness of 
the Center’s mission and social benefit contribution will be achieved, future expansion plans 
(such as a restricted room with secure cages for 15-day observation of animals involved) will 
be included. 
 
6.3.1.3 Competitors 
As potential competitors could be defined the hospitals, the Directorates of Public 
Health and the HCDCP. These organizations don’t provide a holistic approach for the 
evaluation of an animal bite and the assessment of such incidents is performed under the 
pressure of their workload. On the contrary, the ACCM will aim to provide a holistic 
approach with the collaboration of a physician and a veterinarian and this service will be 
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offered by the simultaneous physical presence of highly skilled, trained and experienced 
staff. 
 
6.3.1.4 Collaborators 
Significant help and contribution can be provided by the following national and 
international collaborators: 
- MoH and Ministry of Rural Development and Food (MRDF): Exchange of data and 
sharing expertise. 
- HCDCP, Hospitals Directorates of Public Health, NRL for rabies in animals and Veterinary 
Services: Sharing of epidemiological data and information regarding rabies cases and 
human exposures to animals in a quarterly basis, as well as the laboratory results from 
the post-mortem animal testing. 
- Universities: Collaboration through projects and papers and exchange of knowledge 
with the Medical Schools as well as the Faculty of Veterinary Medicine Universities in 
Greece.  
- Suppliers: The vaccines are exclusively provided by the Hellenic Pasteur Institute and 
the HRIG by the Institute of Pharmaceutical Research and Technology. The consumables 
and other medicines (including anti-tetanus serum, antibiotics or other medicines in 
case of vaccine or HRIG adverse reactions) are provided by Pharmaceutical companies. 
- International Organizations: Collaboration and communication with the Institute 
Pasteur (Paris, France), Anti-rabies Centers (France), EURL for rabies in animals (Nancy, 
France), WHO, Food and Agriculture Organization (FAO), European Food Safety 
Authority (EFSA). This international network enables the sharing of information, data, 
challenges and lessons learnt from various countries.  
 
6.3.1.5 Context 
It is important to analyze the environment (internal and external) in which the ACCM 
will operate. These factors have been extensively described in SWOT matrix (Chapter 6.1.7) 
and PEST analysis (Chapter 6.2.1).  
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6.3.2. Marketing Mix 
The marketing mix (also known as the 4 P’s) is a model that has been defined as the "set 
of marketing tools that the firm uses to pursue its marketing objectives in the target" [28]. 
 
6.3.2.1 Product/Service  
The ACCM will provide timely access, free of charge, safe and effective anti-rabies 
treatment (vaccines and HRIG) following guidelines recommended by WHO with the 
collaboration of trained doctors and veterinarians. It will also maintain a detailed and 
updated bite exposure registry which will be disseminated in all stakeholders on a quarterly 
basis. 
 
6.3.2.2 Place 
Thessaloniki is selected to be the RU that will host the first pilot Anti-rabies Center. The 
ACCM will cover the needs of people bitten in the Region of Central Macedonia. The specific 
location of Thessaloniki has been selected for several reasons (Chapter 6.1.4). 
 
6.3.2.3 Promotion  
Successfully service promotion can be achieved through the following marketing 
communication mix: 
- Poster/leaflets: in order to educate residents on rabies symptoms and prevention. They 
will be designed to include simple graphs with appropriate themes such as: animal 
species able to transmit rabies, signs and symptoms, first actions in the event of a bite. 
Distribution channels can be schools, hospitals, Directorates of Public Health, Veterinary 
Directorates, medical clinics, vet clinics, community centers and hunter associations. 
- Spots on local TV and Radio stations: to advertise the importance of consulting the ACCM 
in case of an animal bite. 
- Videos that will be played in the waiting areas of health facilities. 
- ACCM’s website: a well-designed and informative website will give information of the 
main activities of the Center as well as general information about rabies and first aid 
instructions after an animal bite. 
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- Stands in Greek Conferences (Medical and Health Science as well as Animal and 
Veterinary Science) in order to raise awareness in human and animal health 
professionals. 
- Press release by the MoH and MRDF. 
- Hellenic Medical Association, Medical Association of Thessaloniki and Hellenic 
Veterinarian Association should inform all their members. 
- Rename of a bus stop near the ACCM as “Anti-rabies Center bus station”.  
- Word-of-mouth: an important tool of information dissemination; therefore, providing 
accurate information to targeted individuals, this could have beneficial secondary effects. 
- Post-crisis communication strategy is also required. Since rabies is an emerging infectious 
disease, the public health decision makers must anticipate the potential consequences of 
re-emerging rabies and its press communication. Because of enhanced patient influx 
seeking for PEP, a specific communication strategy is required to provide information to 
the public concerning the epidemiological situation of rabies in Greece and neighboring 
countries as well as to recall indications for PEP. This information can be disseminated via 
the websites of MoH, HCDCP and MRDF. 
 
6.3.2.4 Pricing 
The ACCM will be supervised by the MoH and will be financed mainly through public 
budget appropriation. Therefore, its services will continue to be provided free of charge to 
all people in need for rabies post-exposure treatment. 
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6.4. Management plan 
The following plan will setup the Organizational Structure, Operation plan, Budget 
Estimation, Cost Management and Project Management. 
 
6.4.1. Organizational Structure  
The ACCM will employ a total of 6 members. The team will consist of a General Manager 
(preferably the Manager of General Hospital of Thessaloniki “George Papanikolaou”), one 
doctor, two veterinarians, one nurse and one administrative employee. It may be beneficial 
to the ACCM to begin with meetings and training programs to ensure that adequately 
trained staff members are available in order to prevent personnel shortages. The initial 
choice of only one medical doctor, nurse and administrative employee was made to reduce 
the operating cost. When these employees are on leave, they will be replaced by already 
trained hospital staff. This flexibility does not apply to the vet, who, additionally, may 
occasionally need to work off-site; accordingly, two vets were included in the organizational 
chart of the ACCM.  
 
General Manager: coordinates and manages activities to ensure efficient operations of the 
ACCM. He/she is responsible for ensuring that the vision and mission of the Center are 
implemented efficiently and successfully by the employees.  
Qualifications: 
-  Medicine first bachelor’s degree or Veterinary along with an MBA master’s degree.  
-  At least 15 years of experience in management of health organizations is requested.  
Responsibilities:  
- Oversees all Center functions and addresses issues when they arise.  
- Responsible for all operations of the ACCM.  
- Ensures personnel is properly trained and committed to their duties.  
- Monitors patient flow.  
- Oversees all supply needs. 
- Assures the statistical data are collected and reported to the MoH, MRDF and HCDCP on 
a quarterly basis or upon request. 
 - 42 - 
 
 
Medical Doctor: 
Qualifications: 
- Medicine first degree along with a Master or a PhD degree in Infectious diseases. 
- Training on rabies management is requested.  
- English language (proficiency level) 
- At least 5 years of experience in health organizations is requested.  
Responsibilities:  
- Takes the history by the person exposed along with the veterinarian. 
- Categorizes the animal bite and decides the appropriate vaccination and/or HRIG 
scheme. 
- Reviews evidence of prior vaccination, if available. 
- Oversees the vaccination performed by the nurse. 
- Performs wound cleansing, administration of antibiotics and tetanus prophylaxis. 
- Evaluates and responds to any immediate problems following vaccination (e.g., adverse 
reactions).  
- Ensures that appropriate medications are administered in case of an adverse reaction. 
- Answers questions regarding rabies management.  
- Ensures that all exposures are recorded appropriately.  
- On call duty, 10 days/month (24/7). 
 
Veterinarian:   
Qualifications: 
-  Veterinary first degree along with a Master or a PhD degree in Infectious diseases. 
-  Training on rabies management is requested.  
-  English language (proficiency level). 
Responsibilities:  
- He/she participates in patient history taken by the medical doctor. 
- Clinical examination of the animal, if present. 
- If the animal is not present in the ACCM, the veterinarian contacts with the Veterinary 
regional services or the Municipalities (in case of a stray animal) in order to gain better 
insight to the incident. 
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- Fill in, signs and stamp the animal’s examination follow up report. 
- Answers questions regarding rabies management.  
- Ensures that all exposures are recorded appropriately. 
- On call duty, 10 days/month (24/7). 
 
Nurse:  He/she assists the doctor. 
Qualifications:  
-  Graduate of Department of Nursing, Technological Educational Institute. 
-  At least 3 years of experience is required.  
Responsibilities:  
-  Provides pre- and post-operation care monitoring and administers medication (vaccines 
or/and HRIG). 
-  Takes patient pulses, temperatures and blood pressure.  
-  Provides emotional support to patients and relatives. 
-  Fills in the PEP card. 
-  Tracks vaccine supply by lot numbers and distribution. 
-  Ensures proper rabies vaccine and HRIG storage and that the cold chain is maintained. 
 
Administrative employee:  
Qualifications: 
- Computer literate. 
- English language (minimum requirement in advanced level). 
- An experience of 3 years in administrative positions is required. 
Responsibilities:  
- Checks that the PEP card has doctor signature and stamp.  
- Checks that the animal’s examination follow-up report is completed with the accurate 
description of the animal, accurate tag number, veterinarian input, signature and stamp.  
- Provides encouragement to people to keep the vaccination records in a safe, easy-to-find 
location for future reference.  
- Reminds people to report any future human-to-animal or animal-to-animal exposures. 
- Answers additional questions and provides educational materials regarding rabies and 
other public health issues.  
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- Informs the rabies exposure registry database. 
- Submission of the data in MoH, MRDF and HCDCP on a quarterly basis and upon request. 
The figure of the organizational chart of the ACCM is presented below (Figure 16): 
 
 
 
Figure 16: Organizational chart of ACCM 
 
 
6.4.2. Organizational Plan 
In this section the pre-setting activities, operation/service activities and costs are 
presented and estimated.  
 
6.4.2.1 Pre-setting activities 
The pre-setting activities of the ACCM are presented in Figure 17 by using the work-
breakdown structure (WBS) chart. The WBS is a deliverable-oriented breakdown of a project 
into smaller components. A work breakdown structure is a key project deliverable that 
organizes the team’s work into manageable sections. 
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Figure 17: Pre-setting activities of ACCM presented by work-breakdown structure (WBS) chart 
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6.4.2.2 Service delivery process 
The basic service delivery process is divided into the following steps (Figures 18 and 19):  
1. Registration 
2. Evaluation  
3. Treatment  
4. Record keeping and data management 
5. Exit interview  
6. Other activities 
 
 
 
 
 
 
 
 
 
 
 
Registration  Evaluation  Treatment  Record 
keeping  
and data 
management 
 Exit 
interview 
Figure 18: ACCM’s main operation process  
 
 
Registration: The patient and the animal owner fill in personal information (name, age, sex, 
contact details) on specific forms provided by the ACCM. 
 
Evaluation: Patient history, animal history, clinical examination of patient and animal, 
evaluation of the bite incidence through collaboration between the physician and the 
veterinarian, exposure category and decision on the appropriate treatment by the physician.   
 
Treatment: Provision of first aid (wound washing and cleaning) and administration of rabies 
vaccine with or without HRIG. Fill in the PEP card (vaccine and HRIG used, started date of 
vaccination and the following dates for the booster) and the animal’s examination follow up 
report.  
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Record keeping and data management: ACCM keeps and informs a rabies exposure registry 
containing personal information of the patient (name, age, sex, contact details), history of 
exposure (where, when, biting animal), PEP (vaccine with or without HRIG used, date 
started, completed or not).  It also keeps a report of animal bite containing animal 
information details (species, age, sex, name, tag registry, vaccination status, clinical 
symptoms or not), site of bites, category of exposure, personal information of the animal 
owner, if any. These records are accessible only to authorized personnel and distributed to 
MoH, MRDF and HCDCP on a quarterly basis and upon request.  
 
Exit interview: Documentation and educational information provided to patients and pets 
owners regarding rabies and other public health issues as leaflets and brochures. 
 
 
Other Activities 
Other activities of the Center are depicted in Figure 19. 
 
    
Vaccine management Quality Assessment On call Organization of 
Meetings/Trainings  
Figure 19: ACCM’s other activities 
 
 
Rabies vaccines/HRIG management 
i. Vaccine/HRIG order and receipt: Order and receipt of vaccines and HRIG by the 
Hellenic Pasteur Institute and the Institute of Pharmaceutical Research and 
Technology respectively. Inspection of the container. Record of the temperature 
upon arrival.  
ii. Documentation of vaccines/HRIG: Check the quantity ordered, lot and serial number, 
expiration date. Maintain inventory records. Any storage temperature out of the 
range (2–7 oC) should be immediately reported to the ACCM manager. 
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iii. Vaccine/HRIG storage in a vaccine-designated refrigerator immediately upon arrival 
(2–7 oC).  
iv. Waste disposal: syringes, needles and biologics should be appropriately discarded in 
biohazard containers. 
 
 
Quality Assessment: It ensures clinician’s adherence to standard treatment protocols, 
continuity of care provided to patients, documentation of service delays or excess waiting 
time for a standardized, reliable, comprehensive assessment of PEP treatment. 
 
On call service: On call duty 24/7. 
 
Organization of meetings / trainings for the public and health professionals:  
Organizations of meetings and trainings will be a primary concern of the Center to 
inform the public and health professionals about rabies. The trainings will be designed for 
situations where acquisition of skills and direct communication by experts are needed. 
 
6.4.3. Cost management Plan 
Investment and operating costs of the ACCM are described in detail below. 
6.4.3.1 Investment costs 
The investment costs consist of the pre-setting and the equipment costs.  
The pre-setting activities that have costs are the following. VAT is excluded from all costs 
declared. 
- Construction of the examination area for animals (including plumbing, heating, 
electricity, telephone access) (40 m2): 32,000 €  
- Training course for the one medical doctor and the two veterinarians in the Institute 
Pasteur (Paris, France) for one week: 1,200 € x 3 persons = 3,600 € 
- Catering for the opening day event: 3,000 €  
The equipment cost is estimated 13,628 € and is presented in the following table (table 9).  
Therefore, total investment cost is: 38,600 + 13,628 = 52,228 €. 
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Table 9: Equipment cost (€ VAT excluded) 
Equipment 
Number of 
items 
Cost/item Total cost 
Office desks 8 100 800 
Office chairs 8 55 440 
Waiting room table 1 50 50 
Waiting room chairs  5 20 100 
Weighing scale for human 1 150 150 
Weighing scale for animals 1 250 250 
Laptop 1 800 800 
P/C 5 500 2,500 
Examination tables 2 250 500 
Trolley 2 230 460 
Examination lamps 2 600 1,200 
Refrigerator 2 2,000 4,000 
Thermometers 4 8 32 
Biohazard colored bins 4 80 320 
Sharp bins 4 6.5 26 
Air conditioning 4 500 2,000 
Total cost for equipment     13,628 
 
6.4.3.2 Operating cost 
The operating cost consists of direct and overhead costs. As direct costs are considered 
the consumables and medicines used for first aid, wound care and rabies PEP. Consumables 
are the syringes, needles gloves, cotton, etc., while medicines are the vaccines, HRIG and 
medicines used for the rare adverse reactions caused by vaccine or HRIG. 
Total direct costs for PEP with and without HRIG are estimated to be 1,151.18 € and 
139.3 € respectively (Table 10). For the estimation of PEP costs, a complete course of rabies 
PEP is assumed (5 doses of vaccines at day 0, 3, 7, 14 and 21 or 28 with or without HRIG). 
 
Table 10: Direct cost calculation for PEP (€ VAT excluded) 
Name of the costs vaccine only vaccine with HRIG 
Consumables 2.5 3 
Medicines 136.8 1,148.18 
Total direct cost per potential exposure to rabies virus 139.3 1,151.18 
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The ACCM will apply the Activity Based Cost Management (ABCM) method, in order to 
obtain the overhead cost for the service provided. The ABC system first requires activities 
and activity pools to be defined. Following that, ABC is performed in two stages: (1) 
overhead costs allocated to activity pools and (2) overhead costs allocated to services.  
As shown in table 11, there are eight activity pools for the service provided by the 
ACCM: registration (A1), evaluation (A2), treatment (A3), record keeping and data 
management (A4), exit interview (A5), rabies vaccines/HRIG management (A6), quality 
assessment (A7) and on call service (A8). The organization of meetings and trainings were 
not included since they are not directly involved in the post-exposure treatment. 
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Table 11: Activity Pools and Activities defined for laboratory diagnosis (based on ABC) 
ACTIVITIES POOLS ACTIVITIES 
A1: Registration The patient and the animal owner fill in the requested information on 
specific forms.  
 
A2: Evaluation Medical doctor: Patient history, 
clinical examination of patient, 
evaluation of the bite incidence, 
exposure category and decision on 
the appropriate treatment.  
 
Veterinarian: Animal history, 
clinical examination of animal, 
evaluation of the bite incidence. 
Participates in the patient 
history taken by the medical 
doctor. 
 
A3: Treatment Provision of first aid (wound washing and cleaning), administration of 
rabies vaccine with or without HRIG. Fill in the PEP card and the 
animal’s examination follow up report. 
 
A4: Record keeping and 
data management 
ACCM keeps and informs a rabies exposure registry containing 
personal information of the patient, history of exposure and PEP. It 
also keeps a report of animal bite containing animal information 
details, site of bites, category of exposure and personal information of 
the animal owner. 
 
A5: Exit interview Documentation and educational information provided to patients and 
pets owners regarding rabies and other public health issues as leaflets 
and brochures. 
 
A6: Rabies vaccines/HRIG 
management 
Vaccine/HRIG order and receipt, documentation of vaccines/HRIG, 
vaccine/HRIG storage, waste disposal. 
 
A7: Quality assessment 
 
It allows for standardized, reliable, comprehensive assessment of PEP 
treatment. 
 
A8: On call service On call duty 24/7 
 
First-stage cost drivers, such as number of employees, quantity of medical equipment, 
area (m2) and number of computers, were then determined for the overhead costs in Table 
12. From there, these first-stage cost divers were allocated to activity pools in Table 13. 
 
Table 12: Overhead Costs and Determination of the First Stage Cost Drivers (based on ABC) 
Overhead costs Cost drivers 
Indirect labor Number of employees 
Equipment depreciation Quantity of medical equipment 
Maintenance and repair of equipment Quantity of medical equipment 
Electricity/Heating/cleaning Area (m
2
) 
IT Number of computers 
 - 52 - 
 
Table 13: Allocation of the first stage cost drivers to the activity pools (based on ABC) 
ACTIVITY POOLS Number of employees Quantity of medical equipment Area (m
2
) Number of 
computers 
A1: Registration 1/3* nurse 
 
— 30 1 
A2: Evaluation 1/2** medical doctor 
1/2*** veterinarian 
Medical doctor 
 1 lamp 
 1 weighing scale 
Vet 
•1 lamp 
•1 weighing 
scale 
 
40 
 
40 
 
 
— 
A3: Treatment 1/3 nurse 1 refrigerator/1 thermometer 
1 trolley 
40 — 
A4: Record keeping 
and data 
management 
1/3**** administrative 
employee 
— 30 1 
A5: Exit interview 1/3 administrative 
employee 
— 30 1 
A6: Rabies 
vaccines/HRIG 
management 
1/3 nurse 1 refrigerator / 2 thermometers 
1 trolley 
30 1 
A7: Quality 
assessment 
 
1/3 administrative 
employee 
1/2***** veterinarian 
— 30 2 
A8: On call service 1/2 medical doctor 
1/2 veterinarian 
1/2 veterinarian 
— — — 
TOTAL   270 6 
*1 nurse equally provides services in 3 activities (A1, A3, A6) 
** 1 medical doctor equally provides services in 2 activities (A2, A8) 
***1 veterinarian equally provides services in 2 activities (A2, A8) 
**** 1 administrative employee equally provides services in 3 activities (A4, A5, A7) 
*****1 veterinarian equally provides services in 2 activities (A7, A8) 
 
After allocating the cost drivers to activity pools, overhead costs are distributed by 
using the first-stage cost drivers below. This is summarized in Table 14. 
 
1) Indirect labor 
The following monthly salaries include NIC (National Insurance Cost). 
A1: 1/3 nurse x 1,200 € = 400 € x 12 months = 4,800 €. Total A1: 4,800 € 
A2: 1/2 medical doctor x 1500 € = 750 € x 12 months = 9,000 € 
       1/2 veterinarian x 1500 € = 750 € x 12 months = 9,000 €.  Total A2: 18,000 € 
A3: 1/3 nurse x 1,200 € = 400 € x 12 months = 4,800 €. Total A3: 4,800 € 
A4: 1/3 administrative employee x 1,200 € = 400 € x 12 months = 4,800 €. Total A4: 4,800 € 
A5: 1/3 administrative employee x 1,200 € = 400 € x 12 months = 4,800 €. Total A5: 4,800 € 
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A6: 1/3 nurse x 1,200 € = 400 € x 12 months = 4,800 €. Total A6: 4,800 € 
A7: 1/3 administrative employee x 1,200 € = 400 € x 12 months = 4,800 € 
       1/2 veterinarian x 1500 € = 750 € x 12 months = 9,000 €.  Total A7: 13,800 € 
A8: 1/2 medical doctor x 1,500 € = 750 € x 12 months = 9,000 €  
       1/2 veterinarian x 1500 € = 750 € x 12 months = 9,000 € 
       1/2 veterinarian x 1500 € = 750 € x 12 months = 9,000 €.  Total A8: 27,000 € 
Total cost (A1–A8): 82,800 €. 
 
2)  Overtime payment 
A8: 300 € x 3 (1 medical doctor and 2 veterinarians) = 900 € 
Total cost (A8): 900 €. 
 
3) Equipment depreciation 
A3 & A6: There are 2 pieces of equipment (refrigerators) that are utilized equally in ACCM. 
The annual amortization of the equipment is 440 €. 
Total cost (A3 & A6): 440 €. 
 
4) Maintenance and repair of the equipment 
A3 & Α6: There are 2 pieces of equipment (refrigerators) that are equally utilized. The 
annual repair and maintenance cost of the equipment is 800 €.  
Total cost (A3 & Α6): 800 €. 
 
5) Electricity/heating/cleaning 
The following prices exclude VAT. 
Electricity: The annual electricity consumption for the whole Hospital (area of 54,000 m2) is 
approximately 900,000 €. Therefore, the annual power consumption for the ACCM (area of 
270 m2) is approximately 4,500 €.  
Heating: The annual heating expenses for the whole Hospital are approximately 880,000 €. 
Therefore, the annual heating expenses for the ACCM are approximately 4,400 €. 
Cleaning: The annual cleaning expenses for the whole Hospital are approximately 840,000 €. 
Therefore, the annual cleaning expenses for the ACCM are approximately 4,200 €. 
Total cost (A1–A7): 13,100 €. 
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Allocation/loading rate: 13,100/270 m2 = 48.5 €/m2  
A1: 30 m2 x 48.5 €/m2 = 1,455 €   
A2: 80 m2 x 48.5 €/m2 = 3,880 € 
A3: 40 m2 x 48.5 €/m2 = 1,940 € 
A4: 30 m2 x 48.5 €/m2 = 1,455 € 
A5: 30 m2 x 48.5 €/m2 = 1,455 € 
A6: 30 m2 x 48.5 €/m2 = 1,455 € 
A7: 30 m2 x 48.5 €/m2 = 1,455 € 
 
6) IT: The costs of the IT function are composed of labor compensation, depreciation on 
computers used in the ACCM and maintenance on those computers. The ACCM has 6 
computers having total annual depreciation of approximately 800 €. The annually 
maintenance cost of these computers is 440 €.  
i)  Computer depreciation: 800 € 
ii) Computer maintenance: 440 € 
Total cost (A1, A4–A7): 1,240 € (the total IT cost/computer is approximately 206.7 €) 
Therefore, the total overhead costs for the eight activities (A1-A8) are determined to be 
99,280 €. 
 
Table 14: Distribution of overhead costs by using the first stage cost drivers, based on ABC 
Overhead costs A1 A2 A3 A4 A5 A6 A7 A8 
Indirect labor 4,800 18,000 4,800 4,800 4,800 4,800 13,800 27,000 
Overtime payment — — — — — — — 900 
Equipment depreciation 
— 220 — — — 220 — — 
Maintenance and repair of 
the equipment 
— 400 — — — 400 — — 
Electricity/heating/cleaning 1,455 3,880 1,940 1,455 1,455 1,455 1,455 — 
IT 206.7 — — 206.7 206.7 206.7 413.4 — 
TOTAL 6,462 22,500 6,740 6,462 6,462 7,082 15,668 27,900 
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In the second step, second-stage cost drivers are defined for activity pools, as depicted 
in Table 15. The second-stage cost drivers are the number of patients, time spent (in hours) 
and number of meetings.  
 
Table 15: The Determination of the Second Stage Cost Drivers for Activity Pools (based on ABC) 
Activity pools Cost drivers 
A1: Registration Number of patients 
A2: Evaluation Number of patients 
A3: Treatment Number of patients 
A4: Record keeping and data management Time spent (hours) 
A5: Exit interview Time spent (hours) 
A6: Rabies vaccines/HRIG management Time spent (hours) 
A7: Quality assessment Time spent (hours) 
A8: On call service Number of people asking information about rabies 
 
In order to find the overhead cost, the allocation/loading rates for each activity pool 
should be calculated. The number of patients from Central Macedonia seeking for anti-
rabies vaccination per day could not be predicted and it is in direct connection with the 
epizootiological situation. However, an estimation of 1,200 incidents per year could be 
made without including the phone calls. 
A1: Allocation/loading rate: 6,462 €/1,200 patients = 5.39 €/patient 
A2: Allocation/loading rate: 22,500 € /1,200 patients = 18.75 €/patient 
A3: Allocation/loading rate: 6,740 € /1,200 patients = 5.62 €/patient 
A4: The time spent for record keeping and data management in a year was estimated to be 
864 hours. Allocation/loading rate: 6,462 € /864 hours = 7.5 €/hour 
A5: The time spent during the exit review in a year, was estimated to be 576 hours. 
Allocation/loading rate: 6,462 € /576 hours = 11.2 €/hour 
A6: The time spent for rabies vaccines/HRIG management in a year, was estimated to be 
288 hours. Allocation/loading rate: 7,082 € /288 hours = 24.6 €/hour 
A7: The time spent for quality assessment in a year, was estimated to be 864 hours. 
Allocation/loading rate: 15,668 € /864 hours = 18.1 €/hour 
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A8: Allocation/loading rate: 27,900 € /1,800 people asking information about rabies = 15.5 
€/people asking information about rabies. 
As summarized in Table 16, based on an ABC system, the overhead cost for the service 
provided by the ACCM is 168.76 €. 
 
Table 16: Overhead Cost for ACCM operation (based on ABC) 
Activity pools Loading rate Cost driver 
Overhead cost for 
ACCM operation 
A1: Registration 5.39 €/patient 1 patient 5.39 € 
A2: Evaluation 18.75 €/patient 1 patient 18.75 € 
A3: Treatment 5.62 €/patient 1 patient 5.62 € 
A4: Record keeping and data management 
 
7.4 €/hour 3 hours 22.2 € 
A5: Exit interview 11.2 €/hour 2 hours 22.4 € 
A6: Rabies vaccines/HRIG management 
 
24.6 €/hour 1 hour 24.6 € 
A7: Quality assessment 
 
18.1 €/hour 3 hours 54.3 € 
A8: On call service 
15.5 €/people 
asking info 
1 person asking 
info 
15.5 € 
TOTAL 168.76 € 
 
 
By using ABC, animal health care facilities increase cost effectiveness without 
compromising the quality of service. Moreover, ABC helps animal health care administrators 
to better plan and control the cost of animal health services provided. All these 
improvements in animal health care management work toward alleviating to some degree 
the burden of rising health care costs. 
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6.5. Funding 
6.5.1. Proposed Resource sources 
The ACCM is expected to utilize funds mainly from the state budget in order to cover 
operating costs such as consumables, medicines and the wages of the personnel. Moreover, 
ACCM aims to receive subsidiary by the EU Third Health Programme (2014–2020) which 
serves four objectives including promotion of health, prevention of diseases, facilitation 
access to high quality and safe healthcare. This program is under the ‘Horizon 2020’ 
framework program. 
Additionally, ACCM intends to apply for the European Structural and Investment Fund 
(ESIF) for healthcare (period of 2014–2020) through European Regional Development Fund, 
including financing health infrastructure and equipment. Through this funding ACCM 
intends to cover the construction cost (32,000 €) and the equipment cost (13,628 €). 
Further technical assistance as well as expert support could be provided to the ACCM’s 
staff through a Biennial collaborative agreement (BCA) between WHO and the Hellenic 
MoH. The BCA aligns with WHO’s Twelfth General Programme of Work for 2014–2019, 
which establishes priorities for WHO’s work including promotion of health through a life-
course approach and health systems strengthening. 
Furthermore, funds could be received from non-profit organizations, Institute Pasteur 
(Paris), Hellenic Pasteur Institute and other organizations such as GARC (Global Alliance for 
Rabies Control), in the form of sponsorships as well as donations that could fund the 
activities of ACCM as regards the trainings and meetings. 
 
6.5.2. Closed Consolidated Hospitals (KEN) 
 DRGs (Homogeneous Diagnostic Categories) have been created over the last years as a 
method of compensating hospital expenditure worldwide. In 2012, DRGs were also 
introduced in Greece in the form of Closed Consolidated Hospitals (with the acronym “KEN”) 
including the prospective payment and remuneration of the services provided in hospitals, 
while salaries are not included. KEN are globally considered as one of the most cost-
effective and effective accounting methods for funding health systems. Under this 
perspective, there should be created a specific category for human bite incident defined by 
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a corresponded KEN (with and without HRIG) aiming to develop a consistent model of 
counting, costing, and classifying patient activity. 
6.6. Risk analysis 
 Risk analysis is a process that tends to prioritize the identified risks of a project for 
further actions. The probability and impact of identified risks are the key variables to 
consider. Table 19 in Appendix C presents the risk analysis for the establishment of the 
ACCM. As shown in the proposed risk response plan, the severity of risk is high in the 
following situations: 
- Lack of political will could lead to delay or even cancellation of the project. The 
response strategy would be to make the public collaborate this endeavor by exerting 
pressure on the political leadership. 
- Lack of supplies causing non-provision of PEP treatment by the ACCM. Actions require 
physical inventory of the stock and official documents to the Competent Authorities in 
advance. 
- Inadequate funding for the operation and construction costs of the ACCM due to the 
economic and financial crisis. The response strategy would be the EU funding. 
- Staff recruitment process could be delayed causing postponement in the operation of 
ACCM. In that case, the gap could be temporarily covered by the health professionals 
of the hospital already trained for rabies.  
 - 59 - 
 
6.7. Gantt chart 
An investment plan time-schedule capturing the milestones and the start-up activities 
for ACCM is needed after the completion of the business plan. The milestones and the 
activities are presented in table 17 while a detailed time schedule is given in a Gantt chart 
(Figure 21, Appendix D). The project will start on the 01st of February 2019 and will finish on 
the 30th of June 2020. 
Table 17: ACCM’s milestones/activities 
Milestones Activities 
Project Management 
 
1.1. Charter                                                                
1.2. Plan 
   1.2.1. Scope 
   1.2.2. Schedule 
   1.2.3. Cost                                               
1.3. Project evaluation  
Legal framework 
 
2.1. Contact with the Legal Department of MoH and MRDF          
2.2. Legal and general contracts                                        
2.3. Translating social and health policy                          
2.4. Be informed about International Policy (function of Anti-rabies center) 
Planning 
 
3.1. Contact with Experts and Attend Presentations in Institute Pasteur 
3.2. Resource Allocation 
3.3. Business Plan Preparation 
3.4. Conduct Survey/Interviews 
3.5. Establish Communication with MoH, MRDF, HCDCP, Regional Hospitals, 
Directorates of Public Health, Veterinary Authorities 
3.6. Find Location in the Premises of General Hospital 'George Papanikolaou' 
3.7. Apply for Certificate for Operate 
Design and 
Construction 
 
4.1. Architectural, Electrical, Plumbing, Interior Design 
4.2. Submissions to Local Authorities for Approval 
4.3. Procurement of Materials and Subcontractor 
4.4 Contact with Public Utilities Companies (Electricity, Telecommunication, 
Water Supply) 
Marketing 
 
5.1. Analysis (SWOT, 5 C's, 4 P's) 
5.2. Set Strategy 
5.3. Action Plan 
5.4. Forecasts (e.g., costs) 
5.5. Marketing Collateral 
    5.5.1. Social Media 
    5.5.2. Local TV/Radio Advertisement 
    5.5.3. Leaflets / Poster Brochures 
Human Resources 6.1. Personnel Recruitment Process through A.S.E.P. 
6.2. High Qualified Applicants 
6.3. Training 
Operation 7.1. Opening Day event 
   7.1.1. Digital Marketing (Use of Technology to promote the event) 
   7.1.2. Communication with Local TV/Radio/Press 
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7. Conclusion 
History has shown that if there is compliance and dismantling in the funding and service 
infrastructure regarding infectious diseases, this could be a serious risk factor for their re-
appearance [29]. Greece has been rabies-free country for almost 25 years until the animal 
rabies cases in 2012–2014. Strong, coordinated national and local public health responses 
are still required, as rabies control is considered a public good and the risk of reintroduction 
of the virus is evident. 
 In view of the global strategic plan to eliminate dog-mediated human rabies by 2030, 
except from an effective manifold rabies control, a reduction of the expenditure on PEP is 
needed in order to be most cost-effectively [30]. The number of human anti-rabies 
treatments administrated is considered high. In order to adequately address the gaps in the 
management of animal bites and prevention of rabies, a concerted effort by health and 
veterinary services is required. A closer collaboration between physicians and veterinarians 
would provide a holistic approach, leading to better assessment of the epidemiological 
profile of each case and careful observation of the involved animal. Key One Health 
principles include effective intersectoral partnerships and communication, high levels of 
community participation and strong political will and support at the local and national 
levels. 
Under this prism, the institution of the Anti-rabies Center in Greece should be re-
established, however adapted to current epidemiological data and Greek financial reality. 
Herein, a business plan was conducted including all the necessary information and data to 
highlight the necessity, the feasibility and the sustainability of the project. Moreover, an 
appropriate research on the quality of the facility activities from the point of view of the 
patients is recommended, in order to identify potential gaps and proceed to appropriate 
measures.  
A more comprehensive picture can be drawn and the necessity of re-establishment of the 
Anti-rabies Center institution would be strengthened and further supported if data from all 
animal bite incidents are including in the study and not only the ones that required PEP. This 
could result in obtaining a more complete overview on the injury burden of the population. 
Once awareness of the Center’s mission and social benefit contribution will be achieved, 
future expansion plans (such as a restricted room with secure cages for 15-day observation 
 - 62 - 
 
of animals involved) will be included. This would solve one of the major problems in rabies 
management relating to the control and monitoring of stray animals which were implicated 
in most cases that resulted in PEP. However, some legal impediments and existing 
overlapping of responsibilities need to be overcome. 
For the long-term success of the project, it is important to be viewed as part of a wider 
scale long-term focus on establishing Anti-rabies Centers in other administrative Regions of 
Greece to cover the needs of the whole population. This should be done under the same 
prism that of the linkage and collaboration between the human and animal health sectors 
through the one health approach. 
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Appendix A 
 
Figure 20: ‘Makedonia’ newspaper - March 10th, 1931 issue (page 1) 
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Figure 21: ‘Makedonia’ newspaper - March 10th, 1931 issue (page 4, extract) 
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Appendix B 
Interview (Questions) 
 
1. Interviewee affiliation 
2. France has over 70 Anti-rabies Centers and is a rabies-free country. What are the reasons that 
they were abandoned in Greece? 
3. Re-emergence of rabies in animals in October 2012. What problems have emerged in the 
management of biting cases in humans? 
4. Do you think there is a need to set up an Anti-rabies Center, almost five years after the last 
rabies case in animals in May 2014? 
5. Do you consider the choice of Thessaloniki as the right place to install the first "new type" 
Anti-rabies Centre? 
6. An autonomous unit or integrated into an existing structure (e.g., Hospital, Directorate of 
Public Health)? 
7. Which areas or RUs could this Anti-rabies center serve in order to be able to respond to 
categories II and II exposures in remote areas; 
8. What specialties could be included in the Anti-rabies Center and which do you think should 
be the minimum number of employees? 
9. Do you agree with the coexistence and collaboration of medical doctors and veterinarians in 
an Anti-rabies Center? And if, so why? 
10. Do you think that it would be feasible to have staff visits away from the Anti-rabies Center? 
11. Responsibilities of the Anti-rabies Center. 
12. Days and hours of operation. 24/7 or 8-hours operation; 
13. Do you think the workload of KEELPNO, Directorates of Public Health and Hospitals will be 
facilitated by the establishment of the Anti-rabies Center? 
14. Do you think it will contribute to the rational use of vaccines and HRIG, saving resources 
without harming public health? 
15. What problems could be solved by the establishment of the Anti-rabies Centre? 
16. What are the factors that may hamper the project?  
17. How the Anti-rabies Center could be known to the general public? 
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Appendix C 
Table 18: Risk response plan for ACCM 
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Appendix D 
 
Figure 22: ACCM’s start up time-schedule (Gantt chart) 
